Topical formulation of heparin is effective in reducing the symptoms of superficial venous thrombosis: A monocenter, observer-blind, placebo-controlled randomized study

Panminerva Medica

Volumn 53, Issue 3 SUPPLEMENT, 2011, Pages 3-11

  Belcaro, G ^a   Cesarone, M R ^a   Dugall, M ^a   Feragalli, B ^a   Ippolito, E ^b   Corsi, M ^a   Hosoi, M ^a   Cornelli, U ^a   Ledda, A ^a   Gizzi, G ^a   Luzzi, R ^a   Georgiev, M ^a  

^a UNIVERSITY OF CHIETI   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Heparin; Thrombosis, therapy.; Venous thrombosis

Indexed keywords

HEPARIN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; EDEMA; FEMALE; HUMAN; MALE; MIDDLE AGED; PAIN; PAIN ASSESSMENT; PATHOLOGY; PATHOPHYSIOLOGY; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME; VEIN THROMBOSIS;

ADMINISTRATION, TOPICAL; ADULT; AGED; DOSE-RESPONSE RELATIONSHIP, DRUG; EDEMA; FEMALE; HEPARIN; HUMANS; MALE; MIDDLE AGED; PAIN; PAIN MEASUREMENT; PATIENT COMPLIANCE; SINGLE-BLIND METHOD; TREATMENT OUTCOME; VENOUS THROMBOSIS;

EID: 84859474857     PISSN: 00310808     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Carnero-Vidal LG, Rathbun S, Wakefield TW. Anticoagulant treatment for superficial venous thrombosis. Dis Mon 2010; 56: 574.
2. Taute BM, Melnyk H, Podhaisky H. Alternative Sonographicdiagnoses in patients with clinical suspicion of deep vein thrombosis. MedKlin (Munich). 2010; 105( 9): 619 Epub 2010 Sep 28.
3. Dewar C, Panpher S. Incidence of deep vein thrombosis in patients diagnosed with superficial thrombophlebitis after presenting to an emergency department at out patient deep vein thrombosis service. Emerg Med J 2010; 27( 10): 758. Epub 2010 Jun 17.
4. Timmermans SH, Wlazlo N, Mom EM, Stoffers HE. Thrombophlebitis of the leg: Diagnosis and treatment by the general practitioner. Ned Tijdschr Geneeskd 2010; 154: A1098.
5. Decousus H, Quéré I, Presles E, Becker F, Barrellier MT, Chanut M, Gillet JL, Guenneguez H, Leandri C, Mismetti P, Pichot O, Leizorovicz A; POST (prospective observational superficial thrombophlebitis) study group. Superficial venous thrombosis and venous thromboembolism: A large, prospective epidemiologic study. Ann Intern Med 2010; 152( 4): 218.
6. van Doormaal FF, Atalay S, Brouwer HJ, van derVelde EF, Biiller HR, van Weert HC. Idiopathic superficial thrombophlebitis and the incidence of cancer in primary care patients. Ann Fam Med 2010; 8: 47.
7. vanWeert HC, Pingen F. Recurrent thrombophlebitis as a warning sign for cancer: A case report. Cases J 2009; 2: 153.
8. Cesarone MR, Belcaro G, Agus G, Georgiev M, Errichi BM, Marinucci R, Errichi Se tal. Management of superficial vein thrombosis and thrombophlebitis: Status and expert opinion document Angiology. 2007; 58 Suppl 1: 7S.
9. Belcaro G, Nicolaides AN, Errichi BM, Cesarone MR, Venniker R. Superficial thrombophlebitis of the legs: a randomized, controlled, follow-up study. Angiology 1999; 50( 7): 523.
10. Katzenschlager R, Ugurluoglu A, Minar E, Hirschl M. Liposomal heparin-spraygel in comparison with subcutaneous low molecular weight heparin in subjects with superficial venous thrombosis. A randomized, controlled, open multicentre study. J Kardiol 2003; 10( 9): 375.
11. Gorski G, Szopinski P, Michalak J, Marianowska A, Borkowski M, Geremek M. Liposomal heparin spray: A new formula in adjunctive treatment of superficial venous thrombosis. Angiology 2005; 56: 9.
12. Raake W, Binder M. Treatment of superficial thrombophlebitis. Haemostaseologie 2002; 22: 149.
13. Sznitowska M, Janicki S. Percutaneous absorption of heparin: A critical review of experimental results. Pol Merkuriusz Lek. 2000; 7: 58.
14. Szczesny G, Veihelmann A, Nolte D, Olszewski WL, Messmer K. Heparin protects local skin microcirculation in 210 minutes-long intravital microscopy observations under general anaesthesia. Eur J Med Res 2001; 20/ 6: 175.
15. BelcaroG, Cesarone MR, Vinciguerra G, Ledda A, Dugall M. A plaster combining diclofenac and heparin: microcirculatory evaluation in 2 models of high-perfusion microangiopathy. Angiology 2005;56:707-13. (Pubitemid 41790979)
16. Pacini S, Punzi T, Gulisano M, Cecchi F, Vannucchi S, Ruggiero M. Transdermal delivery of heparin using pulsed current iontophoresis. Pharm Res 2006; 23: 114.
17. Motlekar NA, Youan BB. The quest for non-invasive delivery of bioactive macromolecules: A focus on heparins. J Control Release 2006; 113: 91.
18. Marcus R, Peritz E and Gabriel KR: On closed testing procedures with special reference to ordered analysis of variance. Biometrika 1976; 63: 655-60.
19. Yoon JJ, Chung HJ, Lee HJ, Park TG. Heparin-immobilized biodegradable scaffolds for local and sustained release of angiogenic growth factor. J Biomed Mater Res 2006;79:934-42. (Pubitemid 44915914)
20. Peyman GA, Kazi AA, Riazi-Esfahani M, Aydin E, Kivilcim M, Sanders DR. The effect of combinations of flurbiprofen, low molecular weight heparin and doxycycline on inhibition of corneal neovascularization. Cornea. 2006; 25: 582.
21. Beuth J, Hunzelmann N, Van Leendert R, Basten R, Noehle M, Schneider. Safety and efficacy of local administration of Contractubex to hypertrophic scars in comparison to corticosteroid treatment. Results of a multicenter, comparative epidemiological cohort study in Germany. In Vivo 2006; 20: 277.
22. Incandela L, Belcaro G, Cesarone MR, De Sanctis MT, Griffin M. Microangiopathy and venous ulceration: Topical treatment with Essaven gel - A placebo-controlled, randomized study. Angiology 2001; 52 Suppl 3: S17.
23. Cesarone MR, De Sanctis MT, Incandela L, Belcaro G, Griffin M. Microvascular changes in venous hypertension due to varicose veins after standardized application of Essaven gel-a placebo-controlled, randomized study. Angiology 2001 ; 52 Suppl 3: S 11.
24. Song YK, Kim CK. Topical delivery of low-molecular-weight heparin with surface-charged flexible liposomes. Biomaterials. 2006; 27( 2): 271.
25. Cesarone MR, Belcaro G, Ippolito E, Ricci A, Dugall M. Microcirculatory efficacy of topical treatment with aescin + essential phospholipids gel on transcutaneous PO2 in venous insufficiency. Angiology 2004; 55 Suppl 1: S7.
26. Denda M, Nakanishi K, KumazawaN. Topical application of ionic polymers affects skin permeability barrier homeostasis. Skin Pharmacol Physiol 2005; 18: 36.
27. Parisel C, Saffar L, Gattegno L, Andre V, Abdul-Malak N, Perrier E, Letourneur D. Interactions of heparin with human skin cells: Binding, location, and transdermal penetration. J Biomed Mater Res A. 2003; 67( 2): 517.